-transparent.png){kind=logo}
The effects of cyclosporin A on primary and secondary infection of mice with Listeria monocytogenes was studied both at the microbiological and the histomorphological level. This drug, when given in a dose of 100 mg/kg/day, was found to inhibit the development of protective immunity after primary infection as well as the expression of acquired immunity to challenge infection as determined by counting of bacterial numbers in the spleen. The manifestation of delayed type hypersensitivity was also impaired. When the cellular immune system was functionally intact, the formation of granulomas composed of macrophages and lymphocytes enabled the animals to overcome the Listeria infection. In mice treated with cyclosporin A protective granulomatous reaction during secondary infection did not occur. Instead numerous necropurulent lesions developed in the reticuloendothelial organs, such as spleen and liver, of animals unable to control the lethal infection.
R Strauss, and
B Heymer, and
H Hof
May 1986,
The Veterinary record,
R Strauss, and
B Heymer, and
H Hof
April 1986,
Infection and immunity,
R Strauss, and
B Heymer, and
H Hof
January 2002,
Medicina (Kaunas, Lithuania),
R Strauss, and
B Heymer, and
H Hof
January 1980,
Annales de microbiologie,
R Strauss, and
B Heymer, and
H Hof
October 1966,
Geburtshilfe und Frauenheilkunde,
R Strauss, and
B Heymer, and
H Hof
August 1988,
Infection and immunity,
R Strauss, and
B Heymer, and
H Hof
August 2002,
Current gastroenterology reports,
R Strauss, and
B Heymer, and
H Hof
August 1992,
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
R Strauss, and
B Heymer, and
H Hof
October 1987,
Journal of neurology, neurosurgery, and psychiatry,
R Strauss, and
B Heymer, and
H Hof
December 1958,
Ugeskrift for laeger,
